For US Healthcare Professionals Only
Filter
Quality of life in myasthenia gravis: Post hoc pooled analysis of Phase 3 rozanolixizumab studies
Minimal symptom expression in myasthenia gravis: A post hoc analysis of Phase 3 rozanolixizumab studies
Characterisation of patients with generalised myasthenia gravis on rozanolixizumab treatment in European Managed Access Programmes
Characterisation of patients with generalised myasthenia gravis on zilucoplan treatment in European Managed Access Programmes
Individual item-level analyses of myasthenia gravis-specific outcomes during zilucoplan treatment in RAISE and RAISE-XT
Myasthenia gravis during pregnancy: A descriptive real-world study based on US claims data
Effect of rozanolixizumab on MG-ADL and QMG items: A post hoc Phase 3 final pooled analysis
Effect of rozanolixizumab on ocular symptoms in generalised myasthenia gravis: Analysis of Phase 3 studies